Bactericidal efficiency and modes of action of the novel antimicrobial peptide T9W against Pseudomonas aeruginosa
- PMID: 25753629
- PMCID: PMC4432164
- DOI: 10.1128/AAC.04830-14
Bactericidal efficiency and modes of action of the novel antimicrobial peptide T9W against Pseudomonas aeruginosa
Abstract
The antipseudomonal efficiency and mechanism of action of a novel engineered antimicrobial peptide, T9W, were evaluated in this study. T9W displayed high activity, with a lethal concentration (LC) of 1 to 4 μM against Pseudomonas aeruginosa, including against ciprofloxacin-, gentamicin-, and ceftazidime-resistant strains, even in the presence of 50 to 300 mM NaCl, 1 to 5 mM Ca(2+), or 0.5 to 2 mM Mg(2+). The time-kill curve (TKC) analysis demonstrated concentration-dependent activity, with T9W achieving complete killing in less than 30 min at 1× LC and in less than 5 min at 4× LC. Combination TKC analyses additionally demonstrated a synergistic effect with ciprofloxacin and gentamicin. The selectivity of T9W was further supported by its ability to specifically eliminate P. aeruginosa in a coculture with macrophages without toxicity to the mammalian cells. The results from fluorescent measurement indicated that T9W bound to lipopolysaccharide (LPS) and induced P. aeruginosa membrane depolarization, and microscopic observations and flow cytometry further indicated that T9W targeted the P. aeruginosa cell membrane and disrupted cytoplasmic membrane integrity, thereby causing cellular content release leading to cell death. This study revealed the potential usefulness of T9W as a novel antimicrobial agent against P. aeruginosa.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.
Figures








Similar articles
-
Importance of Tryptophan in Transforming an Amphipathic Peptide into a Pseudomonas aeruginosa-Targeted Antimicrobial Peptide.PLoS One. 2014 Dec 10;9(12):e114605. doi: 10.1371/journal.pone.0114605. eCollection 2014. PLoS One. 2014. PMID: 25494332 Free PMC article.
-
Potential synergy activity of the novel ceragenin, CSA-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa.J Antimicrob Chemother. 2008 Feb;61(2):365-70. doi: 10.1093/jac/dkm457. Epub 2007 Dec 12. J Antimicrob Chemother. 2008. PMID: 18079128
-
In vitro activity of fosfomycin-gentamicin, fosfomycin-ceftazidime, fosfomycin-imipenem and ceftazidime-gentamicin combinations against ceftazidime-resistant Pseudomonas aeruginosa.Southeast Asian J Trop Med Public Health. 2005 Sep;36(5):1239-42. Southeast Asian J Trop Med Public Health. 2005. PMID: 16438151
-
In vitro synergistic effect of ciprofloxacin with aminoglycosides against multidrug resistant-Pseudomonas aeruginosa.Pak J Pharm Sci. 2013 Sep;26(5):1041-4. Pak J Pharm Sci. 2013. PMID: 24035966
-
Evaluation of in vitro synergy between vertilmicin and ceftazidime against Pseudomonas aeruginosa using a semi-mechanistic pharmacokinetic/pharmacodynamic model.Int J Antimicrob Agents. 2015 Feb;45(2):151-60. doi: 10.1016/j.ijantimicag.2014.09.017. Epub 2014 Nov 1. Int J Antimicrob Agents. 2015. PMID: 25465523
Cited by
-
Repurposing a platelet aggregation inhibitor ticagrelor as an antimicrobial against Clostridioides difficile.Sci Rep. 2020 Apr 16;10(1):6497. doi: 10.1038/s41598-020-63199-x. Sci Rep. 2020. PMID: 32300130 Free PMC article.
-
PACAP Is Lethal to Flavobacterium psychrophilum Through Either Direct Membrane Permeabilization or Indirectly, by Priming the Immune Response in Rainbow Trout Macrophages.Front Immunol. 2019 Apr 26;10:926. doi: 10.3389/fimmu.2019.00926. eCollection 2019. Front Immunol. 2019. PMID: 31105711 Free PMC article.
-
Comparative mode of action of the antimicrobial peptide melimine and its derivative Mel4 against Pseudomonas aeruginosa.Sci Rep. 2019 May 8;9(1):7063. doi: 10.1038/s41598-019-42440-2. Sci Rep. 2019. PMID: 31068610 Free PMC article.
-
The synergistic antimicrobial effects of novel bombinin and bombinin H peptides from the skin secretion of Bombina orientalis.Biosci Rep. 2017 Sep 27;37(5):BSR20170967. doi: 10.1042/BSR20170967. Print 2017 Oct 31. Biosci Rep. 2017. PMID: 28894024 Free PMC article.
-
Profiling antimicrobial peptides from the medical maggot Lucilia sericata as potential antibiotics for MDR Gram-negative bacteria.J Antimicrob Chemother. 2019 Jan 1;74(1):96-107. doi: 10.1093/jac/dky386. J Antimicrob Chemother. 2019. PMID: 30272195 Free PMC article.
References
-
- Strateva T, Mitov I. 2011. Contribution of an arsenal of virulence factors to pathogenesis of Pseudomonas aeruginosa infections. Ann Microbiol 61:717–732. doi:10.1007/s13213-011-0273-y. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous